SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-205600
Filing Date
2023-08-08
Accepted
2023-08-08 08:00:52
Documents
14
Period of Report
2023-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d542332d8k.htm   iXBRL 8-K 25297
2 EX-99.1 d542332dex991.htm EX-99.1 61057
6 GRAPHIC g542332g13f91.jpg GRAPHIC 12653
  Complete submission text file 0001193125-23-205600.txt   242255

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20230808.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20230808_lab.xml EX-101.LAB 18757
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20230808_pre.xml EX-101.PRE 11724
8 EXTRACTED XBRL INSTANCE DOCUMENT d542332d8k_htm.xml XML 3503
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 231149408
SIC: 2834 Pharmaceutical Preparations